The short version
15 companies supply this market — deep enough that no single failure threatens the supply.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Potassium Chloride
Potassium Chloride · POTASSIUM CHLORIDE 1.5 g/1.58g · Powder, For Solution · Oral · Strides Pharma Science Limited
NDC 64380-0875-68 · 10 POUCH in 1 CARTON / 1.58 g in 1 POUCH · ANDA · View full market →
Medicare Part D
All Part D pricing →Matched to CMS's representative package for this drug (NDC 72888-0024-07) — same generic, strength, and dosage form. CMS prices one NDC per drug concept, not every package.
ⓘ How this was built
Data sources
- CMS quarterly Prescription Drug Plan Formulary & Pricing files (SPUF)
Method
Negotiated 30-day point-of-sale unit prices and formulary terms aggregated across every unsuppressed Part D and MA-PD plan for the quarter shown. Point of sale means gross of confidential rebates. CMS publishes one representative NDC per drug concept (RxCUI) rather than every package, so these figures come from CMS's representative package for the same drug — matched on generic name, strength, and dosage form. Estimated from MedPAC's program-wide rebate aggregates (June 2023: DIR = 29% of gross Part D spending; brand rebates ≈ 25–40% of gross, generics minimal). Actual rebates are confidential and vary widely by drug — this is a range, not a fact about this drug.
Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.
Plans pay at point of saleⓘ
$1.67per unit
middle half $1.15–$2.30 · 3,801 plans · Apr 1, 2026
Est. net of rebatesⓘ
≈ $1.67
generic — rebates are minimal, so net ≈ gross
Coverage & restrictions
69%of plans cover it
tier 3 · prior auth 0% · step therapy 0% · qty limit 0%
*No drug-level rebate is public — the estimate applies MedPAC's program-wide brand rebate range to this drug's gross price. Tracked here for 10 quarters since 2024.
NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
90-day shortage risk (model v2)
0.1%chance of a new FDA shortage posting for potassium chloride (other) in the next 90 days
sole-source market
For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.
Backtested statistical model over the whole market, not this package alone. Model details →
Where it's made
- analysis · manufacture · pack
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
Is this a "specialty" drug?
There's no legal definition — it meets 1 of 6 public criteria. Why that matters →
- Part D specialty tier
- Costs ≥ $950/fill · avg $24.12 per prescription
- Biologic (BLA)
- Injectable / infused
- Orphan-drug exclusivity
- REMS program · Xywav and Xyrem
Regulatory
- Application
- ANDA211667
- TE code
- AA
- Approval date
- Mar 11, 2021
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Potassium Chloride (Powder, For Solution)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Cardinal Health 107, LLC | POTASSIUM CHLORIDE 1.5 g/1.58g | Sep 3, 2026 | Sep 3, 2026 |
| Advagen Pharma Limited | POTASSIUM CHLORIDE 1.5 g/1.58g | Jul 15, 2026 | Sep 2, 2026 |
| American Health Packaging | POTASSIUM CHLORIDE 1.5 g/1.58g | Jul 15, 2026 | Sep 2, 2026 |
| Bryant Ranch Prepack | POTASSIUM CHLORIDE 1.5 g/1.77g | Jul 15, 2026 | Sep 2, 2026 |
| Carwin Pharmaceutical Associates, LLC | POTASSIUM CHLORIDE .75 g/.79g | Jul 15, 2026 | Sep 2, 2026 |
| Carwin Pharmaceutical Associates, LLC | POTASSIUM CHLORIDE 1.125 g/1.185g | Jul 15, 2026 | Sep 2, 2026 |
| Endo USA, Inc. | POTASSIUM CHLORIDE 1.5 g/1.58g | Jul 15, 2026 | Sep 2, 2026 |
| Epic Pharma, LLC | POTASSIUM CHLORIDE 1.5 g/1.77g | Jul 15, 2026 | Sep 2, 2026 |
| Genus Lifesciences Inc. | POTASSIUM CHLORIDE 1.5 g/1.58g | Jul 15, 2026 | Sep 2, 2026 |
| Guardian Drug Company | POTASSIUM CHLORIDE 1.5 g/1.57g | Jul 15, 2026 | Sep 2, 2026 |
| Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | POTASSIUM CHLORIDE 1.5 g/1.58g | Jul 15, 2026 | Sep 2, 2026 |
| Kesin Pharma Corporation | POTASSIUM CHLORIDE 1.5 g/1.58g | Jul 15, 2026 | Sep 2, 2026 |
| Northstar Rx LLC | POTASSIUM CHLORIDE 1.5 g/1.58g | Jul 15, 2026 | Sep 2, 2026 |
| Strides Pharma Science Limited | POTASSIUM CHLORIDE 1.5 g/1.58g | Jul 15, 2026 | Sep 2, 2026 |
| Upsher-Smith Laboratories, LLC | POTASSIUM CHLORIDE 1.5 g/1 | Jul 15, 2026 | Sep 2, 2026 |
| Virtus Pharmaceuticals, LLC | POTASSIUM CHLORIDE 1.5 g/1.77g | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Potassium Chloride — NDC 64380-0875-68," retrieved September 3, 2026, https://drugdashboards.com/drug/64380087568.
Free to cite with attribution — see how the data is put together.